Researchers from Deakin University reveal how yoyo dieting disrupts gut health, leading to weight regain and obesity-related complications. The study highlights the roles of gut microbiota, hormones, and inflammation in the weight cycling process.
Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 – Biotech Investments
EQS-News: ABIVAX / Key word(s): Conference Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod